![top](data:image/svg+xml,%3Csvg%20xmlns="http://www.w3.org/2000/svg"%20width="16"%20height="16"%3E%3Crect%20fill-opacity="0"/%3E%3C/svg%3E "top")
Anti-COVID property of subcutaneous ivermectin in synergy with zinc among midlife moderately symptomatic patients: a structured summary of a study protocol for a randomised controlled trial.
. N Engl J Med. 2021 Sep 8:NEJMc2113891. doi: 10.1056/NEJMc2113891. Online ahead of print. N Engl J Med. 2021. PMID: 34496196
. Clin Chem Lab Med. 2021 Sep 7. doi: 10.1515/cclm-2021-0700. Online ahead of print. Clin Chem Lab Med. 2021. PMID: 34492749
. Trials. 2021 Sep 6;22(1):591. doi: 10.1186/s13063-021-05487-z. Trials. 2021. PMID: 34488858
.
Item in Clipboard
